Lieff Cabraser partner Katherine Lubin Benson has been appointed to serve on The Bar Association of San Francisco’s (BASF) Board of Directors for 2021. The 2021 BASF officers and board members were installed at the BASF’s Annual Membership Luncheon on December 8, 2020.
The Bar Association of San Francisco is a nonprofit voluntary membership organization of attorneys, law students, and legal professionals in the San Francisco Bay Area. Founded in 1872, BASF enjoys the support of more than 7,500 individuals, law firms, corporate legal departments, and law schools. BASF provides a collective voice for public advocacy, advances professional growth and education, and attempts to elevate the standards of integrity, honor, and respect in the practice of law.
About Katherine Lubin Benson
A partner in Lieff Cabraser’s San Francisco office, Katherine Lubin Benson specializes in securities and derivative suits and antitrust class actions. She was one of the firm’s attorneys heading the shareholder derivative action against Wells Fargo’s current and former officers and directors arising from the bank’s massive illicit sales practices scandal. Katherine was a key member of Lieff Cabraser team representing Co-Lead Plaintiff Fire and Police Pension Association of Colorado in the action, which settled for a $240 million cash payment and corporate governance reforms in late 2018. The settlement received final approval in April 2020, and represents the largest insurer-funded derivative settlement in history. Lieff Cabraser’s work on the case was recognized by the American Antitrust Institute, which honored the firm with the 2020 Outstanding Private Practice Antitrust Achievement award. Katherine was awarded AAI’s Outstanding Antitrust Litigation Achievement by a Young Lawyer award for her contributions to the case.
Katherine served as Class Counsel representing a class of hospitals, third-party payors, and uninsured persons in 29 states and the District of Columbia in an antitrust action against defendants Momenta Pharmaceuticals, Inc. and Sandoz Inc. for their alleged monopolization of enoxaparin, the generic version of the anti-coagulant blood clotting drug Lovenox. The case resulted in a nationwide settlement totaling $120 million, making it the second largest indirect purchaser antitrust pharmaceutical settlement fund in history.
Katherine was recently named as one of six lawyer representatives to the Ninth Circuit Judicial Counsel for the 2020-2023 term, and currently serves on the Board of Directors of the Northern District Practice Program, which provides continuing legal education programing for judges and practitioners in the district. She also serves on the Board of Directors of the East Bay Community Law Center, a non-profit affiliated with Berkeley Law providing free legal services to low-income communities.